
Plasma Therapy Industry Research Report 2025
Description
Summary
Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.
According to APO Research, The global Plasma Therapy market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Plasma Therapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Plasma Therapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Plasma Therapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Plasma Therapy include Terumo, Arthrex, Zimmer Biomet, DePuy Synthes, EmCyte, Regen Lab, ISTO Biologics, Cesca Therapeutics and Weigao, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Plasma Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma Therapy.
The Plasma Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Plasma Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Plasma Therapy Segment by Company
Terumo
Arthrex
Zimmer Biomet
DePuy Synthes
EmCyte
Regen Lab
ISTO Biologics
Cesca Therapeutics
Weigao
REV-MED
Nuo Therapeutics
Plasma Therapy Segment by Type
Pure PRP
Leucocyte-rich PRP
Leukocyte-rich Fibrin (L-PRF)
Plasma Therapy Segment by Application
Orthopedic
Darmatology
Cardiac Muscle Injury
Dental
Nerve Injury
Plasma Therapy Segment by Application
Orthopedic
Darmatology
Cardiac Muscle Injury
Dental
Nerve Injury
Plasma Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasma Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Plasma Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.
According to APO Research, The global Plasma Therapy market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Plasma Therapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Plasma Therapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Plasma Therapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Plasma Therapy include Terumo, Arthrex, Zimmer Biomet, DePuy Synthes, EmCyte, Regen Lab, ISTO Biologics, Cesca Therapeutics and Weigao, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Plasma Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma Therapy.
The Plasma Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Plasma Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Plasma Therapy Segment by Company
Terumo
Arthrex
Zimmer Biomet
DePuy Synthes
EmCyte
Regen Lab
ISTO Biologics
Cesca Therapeutics
Weigao
REV-MED
Nuo Therapeutics
Plasma Therapy Segment by Type
Pure PRP
Leucocyte-rich PRP
Leukocyte-rich Fibrin (L-PRF)
Plasma Therapy Segment by Application
Orthopedic
Darmatology
Cardiac Muscle Injury
Dental
Nerve Injury
Plasma Therapy Segment by Application
Orthopedic
Darmatology
Cardiac Muscle Injury
Dental
Nerve Injury
Plasma Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasma Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Plasma Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
136 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Plasma Therapy by Type
- 2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
- 2.2.2 Pure PRP
- 2.2.3 Leucocyte-rich PRP
- 2.2.4 Leukocyte-rich Fibrin (L-PRF)
- 2.3 Plasma Therapy by Application
- 2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
- 2.3.2 Orthopedic
- 2.3.3 Darmatology
- 2.3.4 Cardiac Muscle Injury
- 2.3.5 Dental
- 2.3.6 Nerve Injury
- 2.4 Assumptions and Limitations
- 3 Plasma Therapy Breakdown Data by Type
- 3.1 Global Plasma Therapy Historic Market Size by Type (2020-2025)
- 3.2 Global Plasma Therapy Forecasted Market Size by Type (2026-2031)
- 4 Plasma Therapy Breakdown Data by Application
- 4.1 Global Plasma Therapy Historic Market Size by Application (2020-2025)
- 4.2 Global Plasma Therapy Forecasted Market Size by Application (2026-2031)
- 5 Global Growth Trends
- 5.1 Global Plasma Therapy Market Perspective (2020-2031)
- 5.2 Global Plasma Therapy Growth Trends by Region
- 5.2.1 Global Plasma Therapy Market Size by Region: 2020 VS 2024 VS 2031
- 5.2.2 Plasma Therapy Historic Market Size by Region (2020-2025)
- 5.2.3 Plasma Therapy Forecasted Market Size by Region (2026-2031)
- 5.3 Plasma Therapy Market Dynamics
- 5.3.1 Plasma Therapy Industry Trends
- 5.3.2 Plasma Therapy Market Drivers
- 5.3.3 Plasma Therapy Market Challenges
- 5.3.4 Plasma Therapy Market Restraints
- 6 Market Competitive Landscape by Players
- 6.1 Global Top Plasma Therapy Players by Revenue
- 6.1.1 Global Top Plasma Therapy Players by Revenue (2020-2025)
- 6.1.2 Global Plasma Therapy Revenue Market Share by Players (2020-2025)
- 6.2 Global Plasma Therapy Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Plasma Therapy Head Office and Area Served
- 6.4 Global Plasma Therapy Players, Product Type & Application
- 6.5 Global Plasma Therapy Manufacturers Established Date
- 6.6 Global Plasma Therapy Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
- 7 North America
- 7.1 North America Plasma Therapy Market Size (2020-2031)
- 7.2 North America Plasma Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 7.3 North America Plasma Therapy Market Size by Country (2020-2025)
- 7.4 North America Plasma Therapy Market Size by Country (2026-2031)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
- 8 Europe
- 8.1 Europe Plasma Therapy Market Size (2020-2031)
- 8.2 Europe Plasma Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 8.3 Europe Plasma Therapy Market Size by Country (2020-2025)
- 8.4 Europe Plasma Therapy Market Size by Country (2026-2031)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
- 9 Asia-Pacific
- 9.1 Asia-Pacific Plasma Therapy Market Size (2020-2031)
- 9.2 Asia-Pacific Plasma Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 9.3 Asia-Pacific Plasma Therapy Market Size by Country (2020-2025)
- 9.4 Asia-Pacific Plasma Therapy Market Size by Country (2026-2031)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
- 10 South America
- 10.1 South America Plasma Therapy Market Size (2020-2031)
- 10.2 South America Plasma Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 10.3 South America Plasma Therapy Market Size by Country (2020-2025)
- 10.4 South America Plasma Therapy Market Size by Country (2026-2031)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
- 11 Middle East & Africa
- 11.1 Middle East & Africa Plasma Therapy Market Size (2020-2031)
- 11.2 Middle East & Africa Plasma Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 11.3 Middle East & Africa Plasma Therapy Market Size by Country (2020-2025)
- 11.4 Middle East & Africa Plasma Therapy Market Size by Country (2026-2031)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
- 12 Players Profiled
- 12.1 Terumo
- 12.1.1 Terumo Company Information
- 12.1.2 Terumo Business Overview
- 12.1.3 Terumo Revenue in Plasma Therapy Business (2020-2025)
- 12.1.4 Terumo Plasma Therapy Product Portfolio
- 12.1.5 Terumo Recent Developments
- 12.2 Arthrex
- 12.2.1 Arthrex Company Information
- 12.2.2 Arthrex Business Overview
- 12.2.3 Arthrex Revenue in Plasma Therapy Business (2020-2025)
- 12.2.4 Arthrex Plasma Therapy Product Portfolio
- 12.2.5 Arthrex Recent Developments
- 12.3 Zimmer Biomet
- 12.3.1 Zimmer Biomet Company Information
- 12.3.2 Zimmer Biomet Business Overview
- 12.3.3 Zimmer Biomet Revenue in Plasma Therapy Business (2020-2025)
- 12.3.4 Zimmer Biomet Plasma Therapy Product Portfolio
- 12.3.5 Zimmer Biomet Recent Developments
- 12.4 DePuy Synthes
- 12.4.1 DePuy Synthes Company Information
- 12.4.2 DePuy Synthes Business Overview
- 12.4.3 DePuy Synthes Revenue in Plasma Therapy Business (2020-2025)
- 12.4.4 DePuy Synthes Plasma Therapy Product Portfolio
- 12.4.5 DePuy Synthes Recent Developments
- 12.5 EmCyte
- 12.5.1 EmCyte Company Information
- 12.5.2 EmCyte Business Overview
- 12.5.3 EmCyte Revenue in Plasma Therapy Business (2020-2025)
- 12.5.4 EmCyte Plasma Therapy Product Portfolio
- 12.5.5 EmCyte Recent Developments
- 12.6 Regen Lab
- 12.6.1 Regen Lab Company Information
- 12.6.2 Regen Lab Business Overview
- 12.6.3 Regen Lab Revenue in Plasma Therapy Business (2020-2025)
- 12.6.4 Regen Lab Plasma Therapy Product Portfolio
- 12.6.5 Regen Lab Recent Developments
- 12.7 ISTO Biologics
- 12.7.1 ISTO Biologics Company Information
- 12.7.2 ISTO Biologics Business Overview
- 12.7.3 ISTO Biologics Revenue in Plasma Therapy Business (2020-2025)
- 12.7.4 ISTO Biologics Plasma Therapy Product Portfolio
- 12.7.5 ISTO Biologics Recent Developments
- 12.8 Cesca Therapeutics
- 12.8.1 Cesca Therapeutics Company Information
- 12.8.2 Cesca Therapeutics Business Overview
- 12.8.3 Cesca Therapeutics Revenue in Plasma Therapy Business (2020-2025)
- 12.8.4 Cesca Therapeutics Plasma Therapy Product Portfolio
- 12.8.5 Cesca Therapeutics Recent Developments
- 12.9 Weigao
- 12.9.1 Weigao Company Information
- 12.9.2 Weigao Business Overview
- 12.9.3 Weigao Revenue in Plasma Therapy Business (2020-2025)
- 12.9.4 Weigao Plasma Therapy Product Portfolio
- 12.9.5 Weigao Recent Developments
- 12.10 REV-MED
- 12.10.1 REV-MED Company Information
- 12.10.2 REV-MED Business Overview
- 12.10.3 REV-MED Revenue in Plasma Therapy Business (2020-2025)
- 12.10.4 REV-MED Plasma Therapy Product Portfolio
- 12.10.5 REV-MED Recent Developments
- 12.11 Nuo Therapeutics
- 12.11.1 Nuo Therapeutics Company Information
- 12.11.2 Nuo Therapeutics Business Overview
- 12.11.3 Nuo Therapeutics Revenue in Plasma Therapy Business (2020-2025)
- 12.11.4 Nuo Therapeutics Plasma Therapy Product Portfolio
- 12.11.5 Nuo Therapeutics Recent Developments
- 13 Report Conclusion
- 14 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.